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Introduction
Bloody sweat is known as hematohidrosis. In this rare clinical 
phenomenon, patients may develop bloody sweat in conditions of 
mental or physical stress with undamaged skin [1]. It can be associated 
with bloody otorrhea, otoerythrosis, bloody tears, or bleeding from the 
forehead, umbilicus, hand, and leg [2, 3, 4]. The probable etiologies for 
hematohidrosis include emotional stress, strain, and extreme exertion, 
fear, vicarious menstruation, systemic diseases, and unknown [1, 5]. 
Patients might present with bloody sweating mostly from the face, 
from unbroken skin. It is also necessary to roll out self-injury [5]. The 
diagnosis is made as witnessed by a medical physician and blood 
is collected from the intact skin [6, 7]. Treatment with propranolol is 
effective in patients with hematohidrosis, as well as psychoanalysis, 
and antianxiety medications are needed in most cases [1, 8]. In this 
study, we described three cases of hematohidrosis and reviewed 
the literature. The purpose is to raise awareness of hematologists, 
pediatricians, and psychiatrists about hematohidrosis.
Case 1
An 8-year-old-girl, Caucasian, presented with bleeding from the 
undamaged skin of the forearm, leg, and face for 6 months, and 
these bleeding attacks were repeated almost every 2 weeks 
(Fig. 1A). The patient had no history of any previous bleeding 
disorders or coagulation disorders in her family. Her mother without 
knowing when she was bleeding, tried to control the patient; as such, 
she did not have self-injury. Her physical examination was normal. 
She was investigated for bleeding disorders, but all tests, including 
platelet count (PLT), prothrombin time (PT), partial thromboplastin 
time (PTT), bleeding time, Factor XIII activity, von Willebrand factor 
(VWF), fibrinogen level and platelet function test were normal. She 
was asked to go to the toilet while the interview with her parents was 
continuing and we saw her bleeding from her face, legs, and abdomen 
when she came back to her parents (Fig. 1A). Detailed history revealed 
that most of her bleedings happened when she went to the toilet or 
when he was feeling lonely. A sample from the bleeding site was sent 
to the coagulation laboratory, which showed 30% hematocrit and the 
peripheral blood smears revealed all components of the blood cells. 
Propranolol (non-cardio selective beta-adrenergic antagonist) 10 mg, 
orally, twice per day was started leading partial improvement. Her 
electrocardiography during treatment with propranolol was normal. 
As a result, bleeding occurred every two months, rather than almost 
every 2 weeks. Three months later, she had significant improvement 
after starting psychotherapy and taking a tricyclic antidepressant 
(nortriptyline 10 mg, orally, once per day at night) as an antianxiety 
medication. She is under a close follow-up with no complaint of 
bleeding events and no adverse events related to her medications 
were observed.
Case 2
A 12-year-old-girl, Caucasian, was referred to hematologist due 
to the bleeding episode from ears, eyes, nostrils, and sublingual 
area almost every 3 weeks without the history of trauma 
(Fig. 1B). Her physical examination was normal. All coagulation 
profiles, including PLT, PT, PTT, platelet function test, factor XIII, 
and VWF were normal. She had no previous history of bleeding 
disorders in the patient or her family. Although she had no history 
of anxiety or fear, psychoanalytic consultation was requested and 
a conflict between the patient and her obsessive mother was detected. 
With a diagnosis of hematohidrosis, propranolol 10 mg, orally, twice 
per day was started with minimal response. Her electrocardiography 
during treatment with propranolol was normal. The bleeding symptoms 
happened approximately every month instead of almost every 3 weeks. 
Additionally, as consulted with a pediatric psychiatrist, treatment with 
antianxiety (nortriptyline 10 mg, orally, once per day at night) along 
with psychotherapy was associated with partial improvement. She is 
under a regular follow-up with no new complaint of bleeding events 
after 7 months and no drug adverse effect.
Case 3
A 14-year-old-girl, Caucasian, who came due to bleeding from the 
undamaged face (Fig. 1C) when he fought with his sister, who was two 
years younger, he developed bleeding from the undamaged face and 
the family was scared and fought with a little sister. Of course, the patient 
had a history of aggression. The physical examination was normal. 
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All coagulation tests like in the previous case were done and were 
found to be normal. According to patient history, physical examination, 
and the normal coagulation test, hematohidrosis was diagnosed for 
her. Thus, propranolol was started with a dosage of 20 mg, orally, 
twice per day, and referred to a psychiatrist that prescribed for her 
antipsychotic drugs, and psychotherapy with family and the patient 
was done. Her electrocardiography during treatment with propranolol 
was normal. Now that one month of patient treatment is over, she 
has recovered and has not been bleeding for the last month. In the 
follow-up, she had not been found with any adverse effects related to 
her medications. Written informed consent was obtained from all the 
patients and their parents.
Discussion
Hematohidrosis is a rare clinical condition that presents with 
the bleeding episode from the undamaged skin. It presents with 
episodes of spontaneous bleeding through intact skin or sweat gland 
orifices, with an unknown cause [1, 4]. The differential diagnosis of 
hematohidrosis includes vasculitis, factitious disorder, Munchausen’s 
by proxy, scurvy, pseudochromhidrosis, and chromhidrosis [9-13]. 
In vasculitis syndrome, the patients usually have systemic signs 
and symptoms. It is important to exactly observe the skin to 
rule out self-injuries [13]. In scurvy, the patients may present 
with bone pain, petechiae, myalgia, easy bruising, swelling, 
perifollicular hemorrhages, corkscrew hairs, and gum bleeding [14]. 
Chromhidrosis is characterized by the excretion of colored sweat 
from apocrine or eccrine sweat glands. In pseudochromhidrosis, 
a much more common disorder, sweat stains are visible after 
discharge from the sweat gland. Pseudochromhidrosis is caused 
by contact between sweat and dyes, chemicals, or chromogenic 
bacteria on the skin [10, 11]. Fear and stress are the most common 
causes of hematohidrosis [15]. The mechanism responsible for 
bleeding in this disorder includes vasoconstriction of vessels, which 
supply the sweat glands after anxiety and consequently, in the post-
stress phase, vasodilatation occurs, leading to the rupture of the 
vessels of the sweat glands and the secretion of bloody sweat to 
the skin [1, 2, 16]. In our report, anxiety and psychological problems 
were strongly accompanying in both cases, causing bleeding from 
undamaged skin that had a good response to anti-anxiety medication 
and psychotherapy. In patients with hematohidrosis, we must be 
sure to have a history of stress and psychological problems, since 
it plays an important role in treating such patients. This approach 
concentrates on alerting physicians, nurses, and health professionals 
to consider different aspects of psychological problems in such rare 
bleeding manifestations along with normal coagulation tests. High 
suspicion to consider hematohidrosis in the pediatric age group 
presents with bleeding symptoms and normal coagulation profiles is 
essential to not miss this rare disorder. Psychiatric consultation and 
initiation of drug therapy with psychotherapy along with propranolol is 
a good management strategy, as observed in our present cases and 
previous repeated cases [17]. Although atropine sulfate transdermal 
patch was used as a treatment option in a study by Biswas et al. [2] 
the results were almost favorable, but it was gradual. However, in our 
study, we could not use atropine sulfate transdermal patch due to 
lack of access, but our patients responded well to propranolol.
Conclusion
As a result, in patients with hematohidrosis, it is better to focus more 
on psychological problems. Because it seems that stress and the 
psychological problem has a more prominent role in the etiology of 
the disease.
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Fig. 1. Bleeding from hand, foot, and abdomen in an 8-year-old 
girl after returning from the toilet at an outpatient clinic (A). 
Bleeding from the ear and forearm in a 12-year-old girl with 
hematohidrosis (B). Bleeding from undamaged face after 
a struggle with her sister in a 14-year-old girl (C)
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